Elderly age as a prognostic marker of 1-year poor outcome for subarachnoid hemorrhage patients through its interaction with admission hydrocephalus.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 22854979)

Published in Anesthesiology on December 01, 2012

Authors

Vincent Degos1, Pierre-Antoine Gourraud, Virginie Trehel Tursis, Rachel Whelan, Chantal Colonne, Anne Marie Korinek, Frédéric Clarençon, Anne-Laure Boch, Aurélien Nouet, William L Young, Christian C Apfel, Louis Puybasset

Author Affiliations

1: Department of Anesthesiology and Critical Care, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris, France.

Articles by these authors

Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg (2003) 6.05

Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg (2007) 4.95

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62

MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell (2010) 3.18

A simple clinical maneuver to reduce laparoscopy-induced shoulder pain: a randomized controlled trial. Obstet Gynecol (2008) 3.01

Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg (2014) 2.97

Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke (2006) 2.68

Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ (2011) 2.38

Aneurysm growth occurs at region of low wall shear stress: patient-specific correlation of hemodynamics and growth in a longitudinal study. Stroke (2008) 2.32

Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke (2007) 2.26

Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke (2003) 2.07

Temporal lobe arteriovenous malformations: anatomical subtypes, surgical strategy, and outcomes. J Neurosurg (2013) 2.02

A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery (2010) 2.01

Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A (2007) 2.01

Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol (2010) 1.96

A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. Anesth Analg (2007) 1.94

Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systematic review and meta-analysis. Arch Intern Med (2006) 1.92

Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg (2002) 1.89

Critical roles of macrophages in the formation of intracranial aneurysm. Stroke (2010) 1.85

Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res (2006) 1.81

Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124. Science (2010) 1.79

Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke (2005) 1.78

A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage. Intensive Care Med (2009) 1.75

Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke (2004) 1.74

Reemergence of stroke deficits with midazolam challenge. Stroke (2002) 1.73

Biology of vascular malformations of the brain. Stroke (2009) 1.70

Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery (2008) 1.69

Experience of diffusion tensor imaging and 1H spectroscopy for outcome prediction in severe traumatic brain injury: Preliminary results. Crit Care Med (2009) 1.69

Minimal homozygous endothelial deletion of Eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse. Cerebrovasc Dis (2012) 1.68

Does the left inferior longitudinal fasciculus play a role in language? A brain stimulation study. Brain (2007) 1.66

Superior outcomes in children compared with adults after microsurgical resection of brain arteriovenous malformations. J Neurosurg (2006) 1.66

Perioperative cognitive decline in the aging population. Mayo Clin Proc (2011) 1.66

Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Anesthesiology (2006) 1.64

Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke (2005) 1.61

S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med (2008) 1.61

Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann Neurol (2011) 1.55

Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet (2013) 1.55

Acute respiratory distress syndrome: lessons from computed tomography of the whole lung. Crit Care Med (2003) 1.54

Validation of in vivo magnetic resonance imaging blood-brain barrier permeability measurements by comparison with gold standard histology. Stroke (2011) 1.53

"Tangential" resection of medial temporal lobe arteriovenous malformations with the orbitozygomatic approach. Neurosurgery (2004) 1.53

Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol (2010) 1.53

Electrocautery interference with intraoperative electrocardiogram mimicking ST-segment depression. J Electrocardiol (2009) 1.52

Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol (2006) 1.51

Opposed effects of hypertonic saline on contusions and noncontused brain tissue in patients with severe traumatic brain injury. Crit Care Med (2006) 1.50

Correlation between lumenal geometry changes and hemodynamics in fusiform intracranial aneurysms. AJNR Am J Neuroradiol (2005) 1.50

Computational approach to quantifying hemodynamic forces in giant cerebral aneurysms. AJNR Am J Neuroradiol (2003) 1.49

Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study. Crit Care Med (2012) 1.45

Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J Cereb Blood Flow Metab (2004) 1.44

Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke (2009) 1.44

A quantitative computed tomography assessment of brain weight, volume, and specific gravity in severe head trauma. Intensive Care Med (2005) 1.41

Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke (2005) 1.40

Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab (2007) 1.39

Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke (2004) 1.39

Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage. Stroke (2007) 1.38

Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine (2010) 1.37

B cell exchange across the blood-brain barrier in multiple sclerosis. J Clin Invest (2012) 1.35

Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol (2004) 1.34

Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI: a pilot study. Arterioscler Thromb Vasc Biol (2012) 1.33

Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke (2004) 1.33

Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm. Acta Neurochir Suppl (2011) 1.32

Phase-contrast magnetic resonance imaging measurements in intracranial aneurysms in vivo of flow patterns, velocity fields, and wall shear stress: comparison with computational fluid dynamics. Magn Reson Med (2009) 1.26

Coexpression of angiogenic factors in brain arteriovenous malformations. Neurosurgery (2005) 1.26

Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery (2004) 1.26

Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development. Stroke (2008) 1.25

Relation between brain lesion location and clinical outcome in patients with severe traumatic brain injury: a diffusion tensor imaging study using voxel-based approaches. Hum Brain Mapp (2009) 1.24

Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation. Am J Physiol Heart Circ Physiol (2008) 1.24

MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci (2006) 1.24

Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain. Front Biosci (2006) 1.23

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma. Neuro Oncol (2006) 1.23

VEGF Induces More Severe Cerebrovascular Dysplasia in Endoglin than in Alk1 Mice. Transl Stroke Res (2010) 1.23

The ARUBA trial: current status, future hopes. Stroke (2010) 1.22

Insulin growth factor-1 gene transfer enhances neurovascular remodeling and improves long-term stroke outcome in mice. Stroke (2008) 1.22

Effect of presenting hemorrhage on outcome after microsurgical resection of brain arteriovenous malformations. Neurosurgery (2005) 1.22

Polymorphisms in transforming growth factor-beta-related genes ALK1 and ENG are associated with sporadic brain arteriovenous malformations. Stroke (2005) 1.21

Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases. Circ Res (2004) 1.20

Cerebellar arteriovenous malformations: anatomic subtypes, surgical results, and increased predictive accuracy of the supplementary grading system. Neurosurgery (2012) 1.20

Numerical simulations of flow in cerebral aneurysms: comparison of CFD results and in vivo MRI measurements. J Biomech Eng (2008) 1.18

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol (2012) 1.18

Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study. Stroke (2012) 1.17

Neutrophil depletion decreases VEGF-induced focal angiogenesis in the mature mouse brain. J Cereb Blood Flow Metab (2007) 1.17

Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis (2008) 1.17

New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples. Arthritis Res Ther (2008) 1.17

Notch-1 signalling is activated in brain arteriovenous malformations in humans. Brain (2009) 1.15

Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. J Cereb Blood Flow Metab (2006) 1.15

Clinical review: Prognostic value of magnetic resonance imaging in acute brain injury and coma. Crit Care (2007) 1.14

The effects of diffuseness and deep perforating artery supply on outcomes after microsurgical resection of brain arteriovenous malformations. Neurosurgery (2007) 1.14

Angiopoietin-2 facilitates vascular endothelial growth factor-induced angiogenesis in the mature mouse brain. Stroke (2005) 1.14

Growth and regression of arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia. Case report. J Neurosurg (2007) 1.14

In vivo transcranial brain surgery with an ultrasonic time reversal mirror. J Neurosurg (2007) 1.13

Coexpression of angiopoietin-1 with VEGF increases the structural integrity of the blood-brain barrier and reduces atrophy volume. J Cereb Blood Flow Metab (2011) 1.12

Morbidity of ventricular cerebrospinal fluid shunt surgery in adults: an 8-year study. Neurosurgery (2011) 1.12

Contribution of bone marrow-derived cells associated with brain angiogenesis is primarily through leukocytes and macrophages. Arterioscler Thromb Vasc Biol (2008) 1.11

Hull down on the horizon: A Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA) trial. Stroke (2012) 1.11